Korrektur
Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”
Human Gene Therapy · 14.06.2026
DOI: 10.1177/10430342261456423 ↗Kurz gefasst
Korrektur in der Zeitschrift Human Gene Therapy, online erschienen am 14.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”. Human Gene Therapy. https://doi.org/10.1177/10430342261456423
Vancouver
Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”. Human Gene Therapy. 2026. doi:10.1177/10430342261456423
BibTeX
@article{euvimed2026,
title = {Corrigendum to: “Enhancing AAV9-UFμDys1 Gene Therapy Efficacy Through Immunosuppression in Mice with Pre-Existing Immunity and Enabling Redosing Strategies for Duchenne Muscular Dystrophy”},
journal = {Human Gene Therapy},
year = {2026},
doi = {10.1177/10430342261456423}
}
EUVIMED